All Stories

  1. Is the SUNRISE study a new dawn in steroid stewardship?
  2. Availability and Costs of Allergic Rhinitis Treatments Across the World: A Survey of ARIA Experts
  3. A 3-year prospective study to assess clinical characteristics and risk factors for exacerbations in patients with asthma-COPD overlap based on the GINA guideline compared with patients with asthma and COPD.
  4. Allergic Rhinitis and Its Impact on Asthma ( ARIA )‐ EAACI Guidelines—2024–2025 Revision: Part II —...
  5. Challenges in the Management of Asthma and COPD in the Asia‐Pacific Region
  6. Validation of diagnosis codes for pleural diseases and procedure codes for relevant respiratory procedures in a healthcare database in Hong Kong: a single tertiary centre study
  7. Allergic Rhinitis and Its Impact on Asthma ( ARIA )‐ EAACI Guidelines—2024–2025 Revision: Part I—Guidelines on Intranasal Treatments
  8. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma ( ARIA )‐EAACI 2024–2025 Guidelines: From Evidence‐to‐Decision Frameworks to Digitalised Shared Decision‐Making Algorithms
  9. Climate Change and Respiratory Care With Inhalers
  10. Prevalence and correlates of breathlessness in adults: an umbrella review and updated systematic review with meta-analysis in general and clinical populations
  11. Establishing the China–UK Cancer Prevention and Control Alliance
  12. Regenerative restoration of chronic obstructive pulmonary disease by human umbilical cord blood small extracellular vesicles
  13. Management of COPD With Cardiovascular Risk in Asia: A Review by the Asian Pacific Society of Respirology COPD Assembly
  14. COPD and Lung Cancer: Shared Risks and Connections
  15. Ground-Glass Opacities on Computed Tomography of the Thorax to Predict Progression of Emphysema: Are We There Yet?
  16. Perceptions of the impact of individual allergic rhinitis symptoms: A survey of ARIA clinical experts
  17. “Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients”. Kiki Waeijen-Smit, Mieke Crutsen, Spencer Keene, Marc Miravitlles, Ernesto Crisafulli, Antoni Torres, Christian...
  18. Green energy and sustainability
  19. Exhaled biomarkers for respiratory diseases
  20. Clinical characteristics and healthcare resource utilization in patients with chronic obstructive pulmonary disease in Hong Kong
  21. Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients
  22. ERS technical standard: Global Lung Function Initiative reference values for exhaled nitric oxide fraction (FENO50)
  23. Comparison of the 12-month impact of COVID-19 and SARS on physiological capacity and health-related quality of life
  24. Clinical characteristics of patients with COPD in Hong Kong
  25. Mortality and readmission after COPD exacerbation-related hospitalization: an individual patient data meta-analysis
  26. Retrospective comparison of the clinical outcomes between low and standard starting doses of intrapleural tissue plasminogen activator in pleural infection
  27. To determine the efficacy of autologous blood patch therapy in reducing air leak in secondary spontaneous pneumothorax.
  28. Global access and patient safety in the transition to environmentally friendly respiratory inhalers: the Global Initiative for Asthma perspective
  29. Can we predict asthma exacerbations?
  30. Risk of air and surface contamination during application of different noninvasive respiratory support for patients with COVID-19
  31. Minimize systemic oral corticosteroids use and reduce harm for patients with asthma
  32. 1-Year Prospective Study of the Relationship of Serial Exhaled Nitric Oxide Level and Asthma Control
  33. Global initiative for asthma: 30 years of promoting evidence‐based asthma care
  34. GOLD 2023 executive summary: comments from Asia's perspective
  35. Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study
  36. Smoking: Quit to win
  37. A Multi-Center Study of the Prevalence and Characteristics of Eosinophilic Phenotype and High IgE Levels Among Chinese Patients with Severe Asthma [Corrigendum]
  38. Hospital Burden of Chronic Obstructive Pulmonary Disease in Hong Kong – The Trend from 2006 to 2014
  39. Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update
  40. Phenotyping empyema by pleural fluid culture results and macroscopic appearance: an 8-year retrospective study
  41. Severe asthma, more than that?
  42. A Multi-Center Study of the Prevalence and Characteristics of Eosinophilic Phenotype and High IgE Levels Among Chinese Patients with Severe Asthma
  43. Advancement of asthma management in the past decade
  44. Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infection
  45. Aspergillus sensitization as a treatable trait in COPD
  46. Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission
  47. Would chronic mucus hypersecretion affect the clinical response to medications of COPD patients?
  48. Leading women in respiratory medicine: The role of the APSR in promoting gender equity and inclusiveness
  49. Respiratory admissions before and during the COVID‐19 pandemic with mediation analysis of air pollutants, mask‐wearing and influenza rates
  50. Sensitisation to recombinant Aspergillus fumigatus allergens and clinical outcomes in COPD
  51. SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022
  52. Effect of Weight Loss and Continuous Positive Airway Pressure on Obstructive Sleep Apnea and Metabolic Profile Stratified by Craniofacial Phenotype: A Randomized Clinical Trial
  53. Virus neutralization of SARS-CoV-2 Omicron variant BA.2 in those vaccinated with three doses of BNT162b2 or CoronaVac vaccines.
  54. Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination
  55. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes
  56. Global Initiative for Asthma Strategy 2021
  57. Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes
  58. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes
  59. The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease
  60. Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes
  61. Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade
  62. Prologue to leading women in respiratory medicine series
  63. A territory‐wide study on the factors associated with recurrent asthma exacerbations requiring hospitalization in Hong Kong
  64. Reply
  65. Predictive value of blood eosinophil count in COPD
  66. Continuous Positive Airway Pressure Does Not Improve Nonalcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea. A Randomized Clinical Trial
  67. Evaluation of bronchial challenge test results for use in assessment of paediatric eczema: a retrospective series
  68. Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies
  69. ARIA‐EAACI statement on asthma and COVID‐19 (June 2, 2020)
  70. Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19
  71. Characterisation of patients hospitalised for asthma exacerbations in Hong Kong
  72. “High-Risk” Clinical and Inflammatory Clusters in COPD of Chinese Descent
  73. Effect of short‐course exercise training on the frequency of exacerbations and physical activity in patients with COPD : A randomized controlled trial
  74. Time course of blood oxygen saturation responding to short-term fine particulate matter among elderly healthy subjects and patients with chronic obstructive pulmonary disease
  75. Real-Time Monitoring of the Effects of Personal Temperature Exposure on the Blood Oxygen Saturation Level in Elderly People with and without Chronic Obstructive Pulmonary Disease: A Panel Study in Hong Kong
  76. Fungal Sensitization and Its Association with Frequent Exacerbations in COPD
  77. Inflammatory Phenotypes in Chronic Obstructive Pulmonary Disease (COPD) of Chinese Descent
  78. Obstructive Sleep Apnea and CPAP Treatment Response in Patients with Non Alcoholic Fatty Liver Disease
  79. Environmental fungal sensitisation associates with poorer clinical outcomes in COPD
  80. Asthma–COPD overlap: No formal definition and simple diagnostic tool so far?
  81. Twenty‐five years of Respirology : Advances in COPD
  82. Comprehensive care for chronic obstructive pulmonary disease
  83. Chronic Obstructive Pulmonary Disease (COPD) in patients of Chinese ethnicity reveal clinically relevant phenotypes
  84. Molecular detection of respiratory pathogens and typing of human rhinovirus of adults hospitalized for exacerbation of asthma and chronic obstructive pulmonary disease
  85. Blood eosinophil count as a predictor of hospital length of stay in COPD exacerbations
  86. GINA 2019: a fundamental change in asthma management
  87. Prevalence and burden of asthma in China: time to act
  88. Towards eradication of chronic obstructive pulmonary disease: a Lancet Commission
  89. Author Correction: A randomized controlled trial of an ambulatory approach versus the hospital-based approach in managing suspected obstructive sleep apnea syndrome
  90. Use of Berlin questionnaire in comparison to polysomnography and home sleep study in patients with obstructive sleep apnea
  91. The interaction between hypertension and obstructive sleep apnea on subjective daytime sleepiness
  92. Exhaled air dispersion from high flow nasal cannula (HFNC) vs CPAP
  93. COMBINATION OF NON CPAP THERAPY IN PATIENTS WITH OSA
  94. Short-course pulmonary rehabilitation and exacerbations and activity of COPD patients over 1 year
  95. Continuous positive airway pressure for obstructive sleep apnoea does not improve asthma control
  96. Identification of chronic obstructive pulmonary disease subgroups in 13 Asian cities
  97. Comorbidities, mortality, and management of chronic obstructive pulmonary disease patients who required admissions to public hospitals in Hong Kong – computerized data collection and analysis
  98. CC16 levels correlate with cigarette smoke exposure in bronchial epithelial cells and with lung function decline in smokers
  99. Year in review 2017: Chronic obstructive pulmonary disease and asthma
  100. Exhaled air dispersion during bag-mask ventilation and sputum suctioning - Implications for infection control
  101. Adherence to a COPD treatment guideline among patients in Hong Kong
  102. Many patients labelled as having mild asthma do not have well-controlled asthma
  103. Drug Treatment for Early-Stage COPD
  104. Randomised controlled trial of the effect of CPAP in uncontrolled nocturnal asthmatic patients with OSAS
  105. The prevalence of unrecognized obstructive sleep apnea syndrome among patients with nocturnal symptoms and poorly controlled asthma
  106. A randomized controlled trial of an ambulatory approach versus the hospital-based approach in managing suspected obstructive sleep apnea syndrome
  107. Year in review 2016: Chronic obstructive pulmonary disease and asthma
  108. Effects of CPAP therapy on visceral fat thickness, carotid intima-media thickness and adipokines in patients with obstructive sleep apnoea
  109. Virological response to peramivir treatment in adults hospitalised for influenza-associated lower respiratory tract infections
  110. Comprehensive care programme for patients with chronic obstructive pulmonary disease: a randomised controlled trial
  111. Acute exacerbation of COPD
  112. Year in review 2015: Asthma and chronic obstructive pulmonary disease
  113. Genetic effects of multiple asthma loci identified by genomewide association studies on asthma and spirometric indices
  114. Mesenteric fat thickness is associated with metabolic syndrome independently of Apnoea-Hypopnoea Index in subjects with obstructive sleep apnoea
  115. A Randomized Controlled Study to Examine the Effect of a Lifestyle Modification Program in OSA
  116. Undiagnosed airflow limitation is common in patients with coronary artery disease and associated with cardiac stress
  117. Comprehensive care programme for patients with chronic obstructive pulmonary disease (COPD) --- A randomized controlled trial (RCT)
  118. Prevalence of obstructive sleep apnea syndrome and CPAP adherence in the elderly Chinese population
  119. A randomized controlled study to examine the effect of lifestyle modification program in obstructive sleep apnea
  120. Antineoplastic effects of 15(S)-hydroxyeicosatetraenoic acid and 13-S-hydroxyoctadecadienoic acid in non-small cell lung cancer
  121. Suicidal ideation in Chinese patients with chronic obstructive pulmonary disease: a controlled study
  122. Exhaled Air Dispersion During Noninvasive Ventilation via Helmets and a Total Facemask
  123. Prevalence of Obstructive Sleep Apnea Syndrome and CPAP Adherence in the Elderly Chinese Population
  124. Year in review 2014: Chronic obstructive pulmonary disease, asthma and airway biology
  125. COPD care programme can reduce readmissions and in-patient bed days
  126. Quality of Life in Older Patients With Chronic Obstructive Pulmonary Disease (COPD) in Hong Kong: A Case-Control Study
  127. Year in review 2013: Chronic obstructive pulmonary disease, asthma and airway biology
  128. Early dislodgement of Indwelling Pleural Catheter ( IPC ): a balancing act
  129. Differences in asthma genetics between Chinese and other populations
  130. Insomnia in Older Adults with Chronic Obstructive Pulmonary Disease (COPD) in Hong Kong: A Case-Control Study
  131. Mesenteric fat thickness is associated with increased risk of obstructive sleep apnoea
  132. Depressive disorders in older patients with chronic obstructive pulmonary disease (COPD) in Hong Kong: a controlled study
  133. Recent advances in asthma biomarker research
  134. Year in review 2012: Asthma and chronic obstructive pulmonary disease
  135. An Adjunct Intervention for Management of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)
  136. Diagnosis of silicotuberculosis by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA)
  137. Changing Prevalence of Allergic Diseases in the Asia-Pacific Region
  138. Determinants of, and reference equation for, exhaled nitric oxide in the Chinese population
  139. Asthma and bronchodilator responsiveness are associated with polymorphic markers of ARG1, CRHR2 and chromosome 17q21
  140. FEV3, FEV6 and their derivatives for detecting airflow obstruction in adult Chinese
  141. Air pollution and chronic obstructive pulmonary disease
  142. Year in review 2011: Asthma, chronic obstructive pulmonary disease and airway biology
  143. Evaluation of the asthma control test: A reliable determinant of disease stability and a predictor of future exacerbations
  144. A prospective cohort study of the long-term effects of CPAP on carotid artery intima-media thickness in Obstructive sleep apnea syndrome
  145. Roles of pollution in the prevalence and exacerbations of allergic diseases in Asia
  146. Erratum to: Atopy in Children with Eczema
  147. Effect of early pulmonary rehabilitation on health care utilization and health status in patients hospitalized with acute exacerbations of COPD
  148. Relationship between asthma control status, the Asthma Control Test™ and urgent health-care utilization in Asia
  149. A longitudinal study of serial BODE indices in predicting mortality and readmissions for COPD
  150. Gene-gene Interactions for Asthma and Bronchodilator Responsiveness in Chinese Adults
  151. The lower the body weight for COPD patients, the more effective is pulmonary rehabilitation?
  152. Effect of Acu-TENS on Post-exercise Expiratory Lung Volume in Subjects with Asthma – a randomized controlled trial
  153. Effects of Air Pollution on Lung Health
  154. PRS11 COST ANALYSIS OF DIFFERENT PHARMACOTHERAPIES IN SUBJECTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE PUBLIC SECTOR OF HONG KONG
  155. Prevalence of Sleep-Disordered Breathing in Chinese Elderly
  156. Can continuous pump feeding reduce the incidence of pneumonia in nasogastric tube-fed patients? A randomized controlled trial
  157. Effect of 4 weeks of Acu-TENS on functional capacity and β-endorphin level in subjects with chronic obstructive pulmonary disease: A randomized controlled trial
  158. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status
  159. Atopy in children with eczema
  160. Validation of Embletta portable diagnostic system for identifying patients with suspected obstructive sleep apnoea syndrome (OSAS)
  161. CXCL 9 and CXCL 10 as Sensitive Markers of Disease Activity in Patients with Rheumatoid Arthritis
  162. Effect of Acu-TENS on post-exercise expiratory lung volume in subjects with asthma—A randomized controlled trial
  163. Asthma Control Test correlates well with the treatment decisions made by asthma specialists
  164. Predicting changes in clinical status of young asthmatics: Clinical scores or objective parameters?
  165. Outdoor air pollution: impact on chronic obstructive pulmonary disease patients
  166. Pulmonary scedosporium infection as a complication of infliximab therapy for ankylosing spondylitis
  167. Activation of Peripheral Th17 Lymphocytes in Patients with Asthma
  168. Identifying Uncontrolled Asthma in Young Children: Clinical Scores or Objective Variables?
  169. Expression and Functional Analysis of Toll-Like Receptors of Peripheral Blood Cells in Asthmatic Patients: Implication for Immunopathological Mechanism in Asthma
  170. Measurement of tumor necrosis factor-α, leukotriene B4, and interleukin 8 in the exhaled breath condensate in patients with acute exacerbations of chronic obstructive pulmonary disease
  171. Patterns of food and aeroallergen sensitization in childhood eczema
  172. Prevalence and risk factors of airflow obstruction in an elderly Chinese population
  173. Validation of a portable recording device (ApneaLink) for identifying patients with suspected obstructive sleep apnoea syndrome
  174. The burden of lung disease in Hong Kong: A report from the Hong Kong Thoracic Society
  175. A one-year prospective study of infectious etiology in patients hospitalized with acute exacerbations of COPD and concomitant pneumonia
  176. Sonographic Measurement of Lateral Parapharyngeal Wall Thickness in Patients with Obstructive Sleep Apnea
  177. Viral Etiology of Acute Exacerbations of COPD in Hong Kong
  178. Effects of air pollution on asthma hospitalization rates in different age groups in Hong Kong
  179. Temporal relationship between air pollutants and hospital admissions for chronic obstructive pulmonary disease in Hong Kong
  180. Reference values of diffusing capacity of non-smoking Chinese in Hong Kong
  181. Increased Expression of Plasma and CD4+ T Lymphocyte Costimulatory Molecule CD26 in Adult Patients with Allergic Asthma
  182. Eczema exacerbation and food atopy beyond infancy: How should we advise Chinese parents about dietary history, eczema severity, and skin prick testing?
  183. Decreased T-bet expression and changes in chemokine levels in adults with asthma
  184. A 1-Year Prospective Study of the Infectious Etiology in Patients Hospitalized With Acute Exacerbations of COPD
  185. Are exhaled breath condensates useful in monitoring asthma?
  186. Polymorphisms in the IL-4, IL-4 Receptor α Chain, TNF-α, and Lymphotoxin-α Genes and Risk of Asthma in Hong Kong Chinese Adults
  187. Nasal CPAP reduces systemic blood pressure in patients with obstructive sleep apnoea and mild sleepiness
  188. Sleep-disordered breathing and continuous positive airway pressure compliance in a group of commercial bus drivers in Hong Kong
  189. 12-year change in prevalence of respiratory symptoms in elderly Chinese living in Hong Kong
  190. Response by J.C.W. Mak, H.C.M. Leung, S.P. Ho, F.W.S. Ko, A.H.K. Cheung, M.S.M. Ip and M.M.W. Chan‐Yeung
  191. Exhaled breath condensate levels of 8-isoprostane, growth related oncogene α and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease
  192. Polymorphisms in manganese superoxide dismutase and catalase genes: functional study in Hong Kong Chinese asthma patients
  193. Aberrant Expression of CC and CXC Chemokines and Their Receptors in Patients with Asthma
  194. Increasing COPD awareness
  195. Updated Spirometric Reference Values for Adult Chinese in Hong Kong and Implications on Clinical Utilization
  196. Exhaled breath condensate levels of eotaxin and macrophage-derived chemokine in stable adult asthma patients.
  197. Sputum bacteriology in patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease and concomitant pneumonia in Hong Kong
  198. Wheezing in Chinese schoolchildren: disease severity distribution and management practices, a community-based study in Hong Kong and Guangzhou
  199. Clinical and atopic parameters and airway inflammatory markers in childhood asthma: a factor analysis
  200. Nitric oxide synthase polymorphisms and asthma phenotypes in Chinese children
  201. The 1-Year Impact of Severe Acute Respiratory Syndrome on Pulmonary Function, Exercise Capacity, and Quality of Life in a Cohort of Survivors
  202. DETERMINING THE LOWER LIMITS OF NORMAL OF SPIROMETRIC REFERENCE VALUES FOR ADULT CHINESE IN HONG KONG
  203. THE LONG-TERM IMPACT OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS) ON PULMONARY FUNCTION, EXERCISE CAPACITY, AND QUALITY OF LIFE IN A COHORT OF SURVIVORS
  204. High levels and gender difference of exhaled nitric oxide in Chinese schoolchildren
  205. Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma
  206. A Comparison of Airway and Serum Matrix Metalloproteinase-9 Activity Among Normal Subjects, Asthmatic Patients, and Patients With Asthmatic Mucus Hypersecretion
  207. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors
  208. Sputum bacteriology in patients with acute exacerbations of COPD in Hong Kong
  209. Analysis of Growth Factors and Inflammatory Cytokines in Exhaled Breath Condensate from Asthmatic Children
  210. Declining asthma prevalence in Hong Kong Chinese schoolchildren
  211. Factors associated with difference in prevalence of asthma in children from three cities in China: multicentre epidemiological survey
  212. Early results of endoscopic lung volume reduction for emphysema
  213. The Effects of Nasal Continuous Positive Airway Pressure on Platelet Activation in Obstructive Sleep Apnea Syndrome
  214. Akute Exazerbation der COPD
  215. Increased macrophage‐derived chemokine in exhaled breath condensate and plasma from children with asthma
  216. Analysis of Th2-specific chemokines in exhaled breath condensate from asthmatic children*1
  217. Cephalometric assessment of craniofacial morphology in Chinese patients with obstructive sleep apnoea
  218. Apoptosis and B-Cell Lymphoma-2 of Peripheral Blood T Lymphocytes and Soluble Fas in Patients with Allergic Asthma
  219. Prevalence of Sleep-Disordered Breathing and Continuous Positive Airway Pressure Compliance
  220. Prevalence of wheeze, bronchial hyper-responsiveness and asthma in the elderly Chinese
  221. Prevalence of snoring and sleep-disordered breathing in a group of commercial bus drivers in Hong Kong
  222. Severe Obstructive Sleep Apnea Is Associated With Left Ventricular Diastolic Dysfunction
  223. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-γ , IL-4, IL-10 and IL-13) in patients with allergic asthma
  224. Determinants of Continuous Positive Airway Pressure Compliance in a Group of Chinese Patients With Obstructive Sleep Apnea
  225. Temporal relationship between air pollution and hospital admissions for asthmatic children in Hong Kong
  226. Prevalence of sleep disturbances in Chinese patients with end-stage renal failure on continuous ambulatory peritoneal dialysis
  227. Effects of Augmented Continuous Positive Airway Pressure Education and Support on Compliance and Outcome in a Chinese Population
  228. Effects of theophylline, dexamethasone and salbutamol on cytokine gene expression in human peripheral blood CD4+ T-cells
  229. Evaluation of the efficacy of a hospital‐based asthma education programme in patients of low socioeconomic status in Hong Kong